查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1981393

圍產期監測設備市場：依技術、設備類型、應用、最終用戶和通路分類－2026-2032年全球市場預測

Intrapartum Monitoring Devices Market by Technology, Device Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，分娩監護設備市場價值將達到 19.8 億美元，到 2026 年將成長到 21.3 億美元，到 2032 年將達到 33.8 億美元，複合年成長率為 7.87%。

主要市場統計數據
基準年 2025 19.8億美元
預計年份：2026年 21.3億美元
預測年份 2032 33.8億美元
複合年成長率 (%) 7.87%

該文件概述了推動出生監測系統創新、改善母嬰結果和提高工作流程效率的迫切臨床和技術需求。

胎兒監護設備正處於母嬰臨床照護與醫療技術進步的關鍵交匯點。這些設備旨在持續或間歇地監測分娩過程中的胎心率和子宮收縮，其雙重目標是最大限度地提高新生兒預後並最大限度地減少不必要的干涉。近年來，這項系統已從傳統的有線系統發展為模組化、無線化和軟體驅動的平台，這些平台優先考慮數據可靠性、臨床醫生工作流程效率和提高患者的活動能力。

感測器創新、無線連接和數據驅動的臨床智慧如何重塑整個分娩護理過程中的監測模式和商業策略。

在分娩監測領域，從核心感測技術到醫療服務運作模式，正在發生變革性的變化。無線遙測、新一代感測器和先進訊號處理技術的突破，使得在傳統產房框架之外進行連續、高精度的監測成為可能。同時，軟體技術的進步也為這些發展提供了補充，該技術將模式識別和預測分析應用於胎兒和子宮數據，從而為臨床醫生提供更早、更準確的潛在異常預警。

了解 2025 年價格調整將如何推動醫療設備價值鏈內的供應鏈多元化、採購系統重組和長期製造策略轉型。

美國2025年關稅調整為分娩監測設備的製造商、經銷商和醫療保健採購商帶來了新的變化。近期營運方面的影響包括對關鍵零件（例如專有感測器、印刷基板組件和行動通訊模組）的供應鏈配置進行重新評估。為此，一些製造商正在加快供應商多元化，增加關鍵零件的庫存緩衝，並考慮將子組件的生產外包到近岸地區，以減輕關稅波動的影響。

將多維細分洞察（將技術選擇、臨床應用、終端用戶環境、設備類別和分銷模式連結起來）轉化為可操作的產品策略。

從技術、應用、最終用戶、設備類型和通路等各個維度對圍產期監護市場進行結構化分析——這些維度共同塑造了產品需求和購買行為——從而揭示了更詳細的市場圖景。從技術面來看，市場可分為兩部分：外部監護和內部監護。外部監測包括胎心監測（CTG）和多普勒超音波，而內部監測包括胎兒頭皮電極和子宮內壓力導管。這些技術差異導致在非侵入性易用性和內部感測器訊號保真度之間需要權衡取捨，從而影響高優先級和低優先級環境下的採購偏好。

美洲、歐洲、中東和非洲以及亞太地區的市場動態和採購行為決定了產品引進管道和商業化方法。

區域趨勢正深刻影響整個圍產期監測生態系統的技術應用、採購慣例和商業策略。在美洲，對數位醫療基礎設施的投資、成熟的醫院系統以及對基於價值的醫療結果的高度重視，正在推動對能夠改善臨床工作流程和互通性的整合監測解決方案的需求。在採購方面，能夠提供全面服務合約、臨床培訓以及證明其對醫療成本影響的證據的供應商越來越受到青睞，這影響供應商如何優先考慮認證和支援服務。

圍產期監測市場的競爭優勢是透過檢驗的臨床平台、一體化的服務交付以及能夠擴展設備價值的策略夥伴關係來建立的。

圍產期監測領域的競爭格局並非由單一功能的差異化所決定，而是由產品系列的廣度、臨床檢驗以及服務生態系統所決定。領先的製造商通常會將硬體平台與專有的訊號處理和使用者介面軟體結合，建立整合解決方案，從而減輕臨床醫生的認知負擔，並增強其決策信心。同時，一群新興的數位醫療公司正在提供先進的分析、雲端連接和遠端監測服務，這些服務是傳統設備產品的有力補充。

製造商和供應商面臨的可操作的策略挑戰，旨在加強供應鏈韌性，展現臨床價值，並利用模組化、互聯的平台實現長期應用。

產業領導企業應採取果斷措施，使產品開發、供應鏈韌性和打入市場策略與不斷變化的臨床和商業性預期保持一致。首先，應實現供應鏈多元化，減少對單一供應商的依賴，並投資於零件標準化，從而實現無需大規模重新認證的替代採購方式。這種方法即使在貿易政策變化的情況下也能確保產品供應的連續性，並支持為醫療保健系統客戶提供更可預測的服務。

透明、多方面的研究框架，結合對臨床醫生的訪談、監管和供應鏈分析以及迭代檢驗，確保了穩健、可操作的見解。

本分析的調查方法整合了多種證據來源和檢驗步驟，以確保其嚴謹性和有效性。主要研究包括對不同醫療機構的產科醫生、採購經理、生物醫學工程師和分銷合作夥伴進行結構化訪談，以了解他們對醫療設備性能、易用性和採購因素的實際觀點。除這些定性研究結果外，對監管申報文件、臨床指南和同行評審文獻的系統性回顧也為技術和臨床方面的論點提供了有據可查的證據支持。

總結了將技術進步、監管變革和供應韌性轉化為圍產期護理中可衡量的臨床和營運改進的觀點。

圍產期監護設備正處於臨床需求與快速技術變革的交匯點，為改善治療效果和服務創新創造了重大機會。不斷演變的醫療模式、日益嚴格的監管要求以及供應鏈重組等多重壓力，都要求製造商提供經過臨床檢驗、互通性且性能穩定的解決方案。從臨床角度來看，向無線和軟體增強型監護的轉變，預計在保持訊號保真度和便於臨床操作的同時，將高品質監護擴展到傳統產房之外。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：圍產期監測設備市場：依技術分類

  • 外部監測
    • 胎心監視器
    • 多普勒超音波檢查
  • 內部監控
    • 胎兒頭皮電極
    • 子宮內下顎導管

第9章：圍產期監測設備市場：依設備類型分類

  • 分娩疼痛監測裝置
    • 外部勞動動力學監測儀
    • 子宮內下顎導管
  • 胎兒監視器
    • 胎心率和子宮收縮監測
    • 多普勒胎兒分娩監視器
    • 胎兒心電圖監視器

第10章：圍產期監測設備市場：依應用領域分類

  • 持續監測
    • 固定系統
    • 無線系統
  • 間歇性監測
    • 手持式多普勒
    • 可攜式顯示器

第11章：圍產期監測設備市場：依最終用戶分類

  • 門診手術中心
  • 居家醫療
  • 醫院
    • 私立醫院
    • 公立醫院
  • 婦產科中心

第12章：圍產期監測設備市場：依通路分類

  • 醫院購買
  • 線上銷售
  • 零售
  • 第三方經銷商

第13章：圍產期監測設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：圍產期監測設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：圍產期監測設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國分娩監護設備市場

第17章：中國分娩監護設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Baxter International Inc.
  • Dragerwerk AG & Co. KGaA
  • Edan Instruments, Inc.
  • General Electric Company
  • Huntleigh Healthcare Limited
  • Koninklijke Philips NV
  • LABORIE MEDICAL TECHNOLOGIES CORP.
  • Medtronic plc
  • Melody International Ltd.
  • MICRODUL AG
  • Natus Medical Incorporated
  • NIHON KOHDEN CORPORATION
  • Nucleus Meditech Company
  • NUVO Inc.
  • Owlet Baby Care, Inc.
  • PeriGen, Inc.
  • Pioneer Biomedical
  • Raydiant Oximetry, Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens AG
  • Stryker Corporation
Product Code: MRR-521BAA36EB40

The Intrapartum Monitoring Devices Market was valued at USD 1.98 billion in 2025 and is projected to grow to USD 2.13 billion in 2026, with a CAGR of 7.87%, reaching USD 3.38 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.98 billion
Estimated Year [2026] USD 2.13 billion
Forecast Year [2032] USD 3.38 billion
CAGR (%) 7.87%

Framing the urgent clinical and technological imperatives driving innovation in labor monitoring systems to enhance maternal and neonatal outcomes while improving workflow efficiency

Intrapartum monitoring devices occupy a critical nexus between maternal-fetal clinical care and advancing medical technology. These devices are designed to continuously or intermittently observe fetal heart rate and uterine activity during labor, with the dual objectives of maximizing neonatal outcomes and minimizing unnecessary interventions. Over recent years, the ecosystem has evolved from legacy wired systems toward modular, wireless, and software-enabled platforms that emphasize data fidelity, clinician workflow efficiency, and improved patient mobility.

Clinical stakeholders seek devices that deliver clear, actionable signals while integrating seamlessly with electronic health record systems and delivery room workflows. At the same time, clinicians and procurement leaders demand evidence of clinical validity, ease of use, and robust infection control processes. As a result, manufacturers are balancing engineering innovation with human factors design and regulatory rigor to meet the needs of obstetric teams in varied care settings.

Transitioning from hospital-centric monitoring to hybrid care models that include ambulatory surgical centers and home healthcare settings has placed new requirements on device portability, wireless reliability, and remote monitoring capabilities. Consequently, the sector is witnessing parallel advances in sensing hardware, signal processing algorithms, and connectivity architectures. Taken together, these trends underscore a field that is both clinically indispensable and technically dynamic, creating an imperative for stakeholders to align product development, clinical validation, and go-to-market strategies around measurable improvements in safety and workflow.

How sensor innovation, wireless connectivity, and data-driven clinical intelligence are reshaping monitoring paradigms and commercial strategies across the intrapartum care continuum

The intrapartum monitoring landscape is undergoing transformative shifts that extend from core sensing technologies to the operational models of care delivery. Technological breakthroughs in wireless telemetry, next-generation sensors, and advanced signal processing are enabling continuous, high-fidelity monitoring outside the confines of the traditional delivery suite. These developments are complemented by software advances that apply pattern recognition and predictive analytics to fetal and uterine data, offering clinicians earlier and more precise alerts of potential compromise.

Simultaneously, care delivery is being reconfigured by the growth of decentralized models: fixed monitoring systems remain central to tertiary hospitals, while wireless and portable solutions enable monitoring in ambulatory surgical centers, maternity centers, and home settings. Payers and health systems emphasizing value-based care are prioritizing devices that demonstrate reductions in avoidable interventions and improved throughput. In regulatory terms, authorities are increasingly focused on software quality, cybersecurity, and interoperability standards, compelling vendors to incorporate compliance by design.

Market participants are also reshaping commercial strategies through collaborations between traditional medical device manufacturers and digital health companies to combine hardware reliability with cloud-native analytics. As a result, product roadmaps are prioritizing user-centered interfaces, secure data transmission, and clinical validation pathways that prove real-world utility. In short, the convergence of sensor innovation, connectivity, and data science is redefining what intrapartum monitoring can deliver for clinicians and expectant families.

Understanding how 2025 tariff revisions are catalyzing supply chain diversification, procurement adjustments, and longer term manufacturing strategy shifts in the medical device value chain

The 2025 tariff adjustments in the United States have introduced a new set of dynamics for manufacturers, distributors, and healthcare purchasers of intrapartum monitoring devices. The immediate operational effect has been a reassessment of supply chain configurations for critical components such as specialized sensors, printed circuit assemblies, and wireless modules. In response, several manufacturers have accelerated diversification of supplier bases, increased inventory buffers for key parts, and evaluated nearshoring for subassemblies to reduce exposure to tariff volatility.

These supply chain responses have downstream implications for procurement cycles and contract negotiations. Hospitals and maternity centers are placing greater emphasis on supplier resilience and transparent cost breakdowns during tendering. Meanwhile, distributors are renegotiating terms with suppliers to preserve service levels, and logistics partners are adapting routing to mitigate customs-related delays. Over time, these adaptations influence product roadmaps by shifting component selection toward parts with more stable sourcing profiles and by encouraging modular designs that can accept alternative supplier inputs with minimal requalification overhead.

Finally, the policy environment has catalyzed conversations about domestic manufacturing incentives, which some manufacturers view as an opportunity to align regulatory, quality, and procurement advantages. While relocation and retooling require capital and regulatory revalidation, the longer-term strategic benefit may include shortened lead times, reduced tariff exposure, and stronger relationships with domestic health systems that prioritize locally produced medical technologies. In essence, tariffs have prompted a strategic reassessment across the value chain that favors resilience, flexibility, and supplier transparency.

Interpreting multidimensional segmentation insights that connect technology choices, clinical applications, end-user environments, device categories, and distribution models into actionable product strategies

A nuanced view of the intrapartum monitoring market emerges when the landscape is structured by technology, application, end user, device type, and distribution pathways as integrated dimensions that shape product requirements and buyer behavior. From a technology perspective, the market is studied across external monitoring and internal monitoring; external approaches encompass cardiotocography and Doppler ultrasonography while internal approaches include fetal scalp electrodes and intrauterine pressure catheters. These technological distinctions create differing clinical trade-offs between noninvasive ease-of-use and the signal fidelity afforded by internal sensors, which in turn inform procurement preferences in high-acuity versus lower-acuity settings.

When analyzed by application, the market is studied across continuous monitoring and intermittent monitoring. Continuous monitoring displays a bifurcation between fixed systems that anchor delivery suite monitoring and wireless systems that enable mobility and remote oversight. Intermittent monitoring includes handheld Doppler devices and portable monitors that support routine checks and community-based care. The choice between continuous and intermittent approaches reflects clinical protocols, staff availability, and the care setting's tolerance for investment in infrastructure.

Examining end users clarifies deployment patterns across ambulatory surgical centers, home healthcare providers, hospitals, and maternity centers; within hospitals, distinctions between private and public institutions influence procurement cycles, budgetary constraints, and service expectations. Device type further refines product positioning as the market is studied across contraction monitoring devices and fetal monitoring devices. Contraction monitoring is differentiated into external tocodynamometers and intrauterine pressure catheters, while fetal monitoring encompasses cardiotocography monitors, Doppler fetal monitors, and fetal ECG monitors, each offering distinct trade-offs in fidelity, invasiveness, and clinical applicability.

Lastly, distribution channel dynamics-spanning hospital purchase, online sales, retail sales, and third-party distributors-shape availability, post-sale service expectations, and pricing strategies. Integrated manufacturers with direct hospital relationships often emphasize installation and training, whereas online and retail channels prioritize ease of ordering and rapid delivery. Taken together, these segmentation lenses reveal that successful offerings must be engineered and marketed in ways that reflect the interplay of clinical requirements, procurement complexity, and distribution realities.

Regional market dynamics and procurement behaviors across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine adoption pathways and commercialization approaches

Regional dynamics exert a strong influence on technology adoption, procurement practices, and commercial strategy across the intrapartum monitoring ecosystem. In the Americas, investment in digital health infrastructure, mature hospital systems, and a strong emphasis on value-based outcomes drive demand for integrated monitoring solutions that can demonstrate improved clinical workflows and interoperability. Procurement tends to favor vendors that provide comprehensive service agreements, clinical training, and evidence of cost-of-care impact, which informs how suppliers prioritize certifications and support offerings.

In Europe, the Middle East, and Africa, regulatory harmonization across parts of Europe is balanced by heterogeneous procurement norms and budget constraints in many markets. Public healthcare purchasers often emphasize total cost of ownership and long procurement cycles, whereas private maternity centers may pursue differentiated technology to attract patients. Across the region, data privacy and cybersecurity requirements shape product development priorities, and multinational suppliers must tailor compliance approaches to local regulatory frameworks.

The Asia-Pacific region is characterized by rapid adoption in urban centers, a strong supplier and manufacturing presence, and an expanding private healthcare sector that demands both advanced technologies and cost-effective models. Rural and peri-urban care settings in several markets present opportunities for portable and low-power devices that enable decentralized monitoring. As a result, product strategies that include tiered features, localized technical support, and supply chain partnerships are especially effective in driving adoption across diverse geographies. Across all regions, cross-border trade dynamics and regulatory alignment play decisive roles in how companies deploy resources and prioritize market entry.

How competitive advantage in the intrapartum monitoring market is built through validated clinical platforms, integrated service offerings, and strategic partnerships that extend device value

Competitive dynamics in intrapartum monitoring are shaped less by single-feature differentiation and more by portfolio breadth, clinical validation, and service ecosystems. Leading manufacturers often combine hardware platforms with proprietary signal processing and user interface software to create integrated solutions that reduce clinician cognitive load and enhance decision confidence. Meanwhile, an emerging cohort of digital health firms contributes advanced analytics, cloud connectivity, and remote monitoring services that complement traditional device offerings.

Companies are increasingly pursuing hybrid commercial models that mix direct hospital sales with channel partnerships, online ordering, and distributor networks to address varied procurement preferences. In parallel, investment in clinical evidence generation-through observational studies, randomized trials, and real-world evidence collection-has become a central competitive lever, providing the foundation for guideline inclusion and payer conversations. Aftermarket services such as training programs, preventive maintenance, and device-as-a-service options are differentiators that strengthen customer retention and create recurring revenue streams.

Finally, strategic alliances between device manufacturers and health systems, software vendors, or contract manufacturers are accelerating time-to-market and expanding capability stacks. These alliances enable faster regulatory pathways for combined hardware-software propositions, allow access to complementary sales channels, and support the scaling of remote monitoring services. Collectively, these company-level approaches emphasize the importance of clinical validation, service excellence, and ecosystem partnerships in sustaining competitive advantage.

Practical strategic imperatives for manufacturers and suppliers to bolster supply resilience, validate clinical value, and leverage modular, connected platforms to win long-term adoption

Industry leaders should take decisive steps to align product development, supply chain resilience, and market access strategies with evolving clinical and commercial expectations. First, diversify supply chains to reduce single-source exposure and invest in component standardization to enable alternative sourcing without extensive requalification. This approach preserves product continuity in the face of trade policy shifts and supports more predictable service commitments to health system customers.

Second, prioritize investments in wireless connectivity, cybersecurity, and cloud-enabled analytics to support remote monitoring and telehealth workflows. These capabilities must be paired with rigorous clinical validation and transparent performance metrics to earn clinician trust. Third, design modular product architectures that allow incremental upgrades in software and sensing capabilities; modularity reduces upgrade costs for customers and accelerates the deployment of new analytical features.

Fourth, engage proactively with payers and health system procurement teams to build reimbursement narratives grounded in clinical outcomes and operational efficiency. Demonstrable reductions in unnecessary interventions, improved throughput, and better patient experience will be central to those conversations. Fifth, expand service offerings to include training, preventative maintenance, and outcome-driven support contracts that align vendor incentives with clinical success. Finally, accelerate partnerships with digital health firms, academic centers, and local manufacturing partners to combine clinical credibility, analytic capability, and supply chain flexibility. These strategic moves create a durable foundation for growth and resilience in a shifting policy and clinical environment.

A transparent, multi-method research framework combining clinician interviews, regulatory and supply chain analysis, and iterative validation to ensure robust actionable insights

The research methodology underpinning this analysis integrates multiple evidence streams and validation steps to ensure rigor and relevance. Primary research included structured interviews with obstetric clinicians, procurement leaders, biomedical engineers, and distribution partners across varied healthcare settings to capture frontline perspectives on device performance, usability, and procurement drivers. These qualitative inputs were complemented by systematic reviews of regulatory filings, clinical guidelines, and peer-reviewed literature to ground technological and clinical claims in documented evidence.

To map supply chain dynamics and tariff impacts, the methodology incorporated supplier mapping exercises, trade flow analyses, and input from logistics specialists to identify points of vulnerability and common mitigation strategies. Data triangulation techniques were employed to reconcile divergent inputs and validate assumptions. In addition, scenario testing and sensitivity analyses were used to examine how changes in procurement preferences, care models, and policy shifts could alter strategic priorities for stakeholders.

Quality assurance included cross-validation workshops with external clinical advisors and technical reviewers, as well as iterative checks for internal consistency and traceability to source data. Limitations and uncertainties were explicitly documented, and where evidence gaps existed, the analysis identified high-priority areas for further primary study. Overall, the methodology emphasizes transparency, multi-stakeholder validation, and a balance between technical detail and strategic applicability.

Concluding perspectives on translating technological advances, regulatory changes, and supply resilience into measurable clinical and operational improvements in intrapartum care

Intrapartum monitoring devices stand at the intersection of clinical necessity and rapid technological change, creating significant opportunities for improved outcomes and service innovation. The combined pressures of evolving care models, heightened regulatory expectations, and supply chain realignment are pushing manufacturers to deliver solutions that are clinically validated, interoperable, and resilient. From a clinical perspective, the move toward wireless, software-enhanced monitoring offers the potential to extend high-quality oversight beyond the traditional delivery room while preserving signal fidelity and clinician usability.

Commercially, companies that integrate hardware reliability with advanced analytics, flexible service models, and demonstrated outcome improvements will be best positioned to succeed. Procurement stakeholders will increasingly reward transparent supply chains, strong post-sale support, and clear evidence of impact on care pathways. As stakeholders adapt to policy changes and shifting care delivery models, collaboration across clinical, technical, and commercial domains will be essential. Ultimately, the path forward requires a disciplined focus on clinical evidence, system interoperability, and supply chain adaptability to translate technological promise into measurable improvements in maternal and neonatal care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intrapartum Monitoring Devices Market, by Technology

  • 8.1. External Monitoring
    • 8.1.1. Cardiotocography
    • 8.1.2. Doppler Ultrasonography
  • 8.2. Internal Monitoring
    • 8.2.1. Fetal Scalp Electrode
    • 8.2.2. Intrauterine Pressure Catheter

9. Intrapartum Monitoring Devices Market, by Device Type

  • 9.1. Contraction Monitoring Device
    • 9.1.1. External Tocodynamometer
    • 9.1.2. Intrauterine Pressure Catheter
  • 9.2. Fetal Monitoring Device
    • 9.2.1. Cardiotocography Monitors
    • 9.2.2. Doppler Fetal Monitors
    • 9.2.3. Fetal ECG Monitors

10. Intrapartum Monitoring Devices Market, by Application

  • 10.1. Continuous Monitoring
    • 10.1.1. Fixed Systems
    • 10.1.2. Wireless Systems
  • 10.2. Intermittent Monitoring
    • 10.2.1. Handheld Doppler
    • 10.2.2. Portable Monitors

11. Intrapartum Monitoring Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Home Healthcare
  • 11.3. Hospitals
    • 11.3.1. Private Hospital
    • 11.3.2. Public Hospital
  • 11.4. Maternity Centers

12. Intrapartum Monitoring Devices Market, by Distribution Channel

  • 12.1. Hospital Purchase
  • 12.2. Online Sales
  • 12.3. Retail Sales
  • 12.4. Third-Party Distributors

13. Intrapartum Monitoring Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Intrapartum Monitoring Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Intrapartum Monitoring Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Intrapartum Monitoring Devices Market

17. China Intrapartum Monitoring Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Baxter International Inc.
  • 18.6. Dragerwerk AG & Co. KGaA
  • 18.7. Edan Instruments, Inc.
  • 18.8. General Electric Company
  • 18.9. Huntleigh Healthcare Limited
  • 18.10. Koninklijke Philips N.V.
  • 18.11. LABORIE MEDICAL TECHNOLOGIES CORP.
  • 18.12. Medtronic plc
  • 18.13. Melody International Ltd.
  • 18.14. MICRODUL AG
  • 18.15. Natus Medical Incorporated
  • 18.16. NIHON KOHDEN CORPORATION
  • 18.17. Nucleus Meditech Company
  • 18.18. NUVO Inc.
  • 18.19. Owlet Baby Care, Inc.
  • 18.20. PeriGen, Inc.
  • 18.21. Pioneer Biomedical
  • 18.22. Raydiant Oximetry, Inc.
  • 18.23. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 18.24. Siemens AG
  • 18.25. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES INTRAPARTUM MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA INTRAPARTUM MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER ULTRASONOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER ULTRASONOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER ULTRASONOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL SCALP ELECTRODE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL SCALP ELECTRODE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL SCALP ELECTRODE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL TOCODYNAMOMETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL TOCODYNAMOMETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL TOCODYNAMOMETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER FETAL MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER FETAL MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER FETAL MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL ECG MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL ECG MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL ECG MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FIXED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FIXED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FIXED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY WIRELESS SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY WIRELESS SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY WIRELESS SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HANDHELD DOPPLER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HANDHELD DOPPLER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HANDHELD DOPPLER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PORTABLE MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PORTABLE MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PORTABLE MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY MATERNITY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY MATERNITY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY MATERNITY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY RETAIL SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY RETAIL SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY RETAIL SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. GCC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. GCC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. GCC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 223. GCC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 224. GCC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. GCC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 226. GCC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 227. GCC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. GCC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2032 (USD MILLION)
  • TABLE 229. GCC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 230. GCC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. GCC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 232. GCC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 259. G7 INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 260. G7 INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. G7 INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 262. G7 INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 263. G7 INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. G7 INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 265. G7 INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 266. G7 INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 267. G7 INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2032 (USD MILLION)
  • TABLE 268. G7 INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 269. G7 INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. G7 INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 271. G7 INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 272. NATO INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 273. NATO INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 274. NATO INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 275. NATO INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 276. NATO INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. NATO INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 278. NATO INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 279. NATO INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. NATO INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2032 (USD MILLION)
  • TABLE 281. NATO INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 282. NATO INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. NATO INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 284. NATO INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 285. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES INTRAPARTUM MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TY